Skip to content
Trial Eligibility
Menu

Study of Circulating Monocytes in Patients With Ischemic Vascular Disease

NCT04321512

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

The purpose of this research study is to discover the functions of circulating white blood cells, called monocytes, and associated circulating substances in heart attack and ischemic stroke patients. Ischemic Strokes (clots) occur as a result of an obstruction within a blood vessel supplying blood to the brain. A type of monocyte carrying a surface marker called "P2X4" helps the immune system sense and respond to danger signals from the body such as heart muscle and brain tissue injuries.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Myocardial Infarction
  • Stroke, Ischemic
  • Ischemia

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
18 years and older
Sex
All
Healthy volunteers
Accepted
Sponsor
UConn Health
Last updated on ClinicalTrials.gov
August 17, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Connecticut · 1

  • University of Connecticut Health Center · Farmington, CT

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.